Statins are cardioprotective

by Yuejin Yang

Researchers demonstrate decreased 'no-reflow' and better preservation of ventricular function in animals treated for only two days with a statin.

Yuejin Yang, Fuwai Heart Hospital, Beijing, China
Yuejin Yang, Fuwai Heart Hospital, Beijing, China

Long-term treatment with statins is known to lower cholesterol and prevent heart attacks and strokes. Now a novel beneficial action of statins has been reported in a study published online in the British Journal of Pharmacology (August - www.nature.com/bjp). This suggests the action only needs a few days of treatment, is independent of cholesterol lowering and helps the heart to recover after a heart attack. Following an attack, blood does not flow correctly into vessels in the heart, even when they open again. Increasing the blood flow in these vessels would decrease the area known as ‘no-reflow’ and restore more of the ventricular function.

Jing-Lin Zhao and colleagues demonstrate decreased ‘no-reflow’ and better preservation of ventricular function in animals treated for only two days with a statin - simvastatin. They also identify the mechanism underlying this cardio-protective action, showing that the observed beneficial effects of simavastatin are abolished by blocking the KATP channel in mitochondria.

Their results suggest that taking statins long-term not only reduces the likelihood of a heart attack, it could also allow the heart to recover more fully from heart attacks by decreasing the damage done to heart muscle.

Author:
Yuejin Yang (Fuwai Heart Hospital, Beijing, China)
e-contact: realplayone@yahoo.com.cn

30.08.2006

More on the subject:

Related articles

Photo

News • Epigenetic biomarkers

Revealing risk of cardiovascular disease in type 2 diabetes

Type 2 diabetes greatly increases the risk of heart attacks, strokes, anginas, and other coronary heart diseases. Therefore, biomarkers to predict individual risk are needed, experts say.

Photo

News • Cardiovascular benefits and risks of CPAP

Sleep apnoea treatment improves heart health for some (but makes it worse for others)

A treatment commonly used for obstructive sleep apnoea (OSA), lowers the risk of serious cardiovascular events in some patients but not others, according to new research.

Photo

News • Sex differences of coronary microvascular dysfunction

Study reveals hidden heart risks in women with type 2 diabetes

Women with type 2 diabetes are nearly twice as likely as men to have hidden heart damage, according to a major new study. This could lead to sex-specific risk assessment and treatments.

Related products

Subscribe to Newsletter